Annual Shareholders Equity
$157.51 M
+$147.16 M+1422.10%
31 December 2023
Summary:
Soleno Therapeutics annual stockholders equity is currently $157.51 million, with the most recent change of +$147.16 million (+1422.10%) on 31 December 2023. During the last 3 years, it has risen by +$139.71 million (+785.22%). SLNO annual shareholders equity is now at all-time high.SLNO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$264.70 M
-$16.06 M-5.72%
30 September 2024
Summary:
Soleno Therapeutics quarterly stockholders equity is currently $264.70 million, with the most recent change of -$16.06 million (-5.72%) on 30 September 2024. Over the past year, it has increased by +$107.19 million (+68.06%). SLNO quarterly shareholders equity is now -5.72% below its all-time high of $280.76 million, reached on 30 June 2024.SLNO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLNO Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +68.1% |
| 3 y3 years | +785.2% | +1387.7% |
| 5 y5 years | +953.8% | +1670.9% |
SLNO Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1422.1% | -5.7% | +9930.3% |
| 5 y | 5 years | at high | +1422.1% | -5.7% | +9930.3% |
| alltime | all time | at high | +516.0% | -5.7% | +724.6% |
Soleno Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $264.70 M(-5.7%) |
| June 2024 | - | $280.76 M(+95.8%) |
| Mar 2024 | - | $143.39 M(-9.0%) |
| Dec 2023 | $157.51 M(+1422.1%) | $157.51 M(+578.3%) |
| Sept 2023 | - | $23.22 M(+86.9%) |
| June 2023 | - | $12.43 M(+370.9%) |
| Mar 2023 | - | $2.64 M(-74.5%) |
| Dec 2022 | $10.35 M(-41.8%) | $10.35 M(-31.9%) |
| Sept 2022 | - | $15.20 M(-25.2%) |
| June 2022 | - | $20.31 M(-23.3%) |
| Mar 2022 | - | $26.46 M(+48.7%) |
| Dec 2021 | $17.79 M(-60.9%) | $17.79 M(-11.9%) |
| Sept 2021 | - | $20.20 M(-26.4%) |
| June 2021 | - | $27.44 M(-27.0%) |
| Mar 2021 | - | $37.57 M(-17.5%) |
| Dec 2020 | $45.55 M(+204.7%) | $45.55 M(-5.1%) |
| Sept 2020 | - | $48.01 M(-14.5%) |
| June 2020 | - | $56.18 M(+492.5%) |
| Mar 2020 | - | $9.48 M(-36.6%) |
| Dec 2019 | $14.95 M | $14.95 M(+0.4%) |
| Sept 2019 | - | $14.88 M(+7.5%) |
| June 2019 | - | $13.84 M(-41.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $23.63 M(-22.3%) |
| Dec 2018 | $30.41 M(+13.4%) | $30.41 M(+114.1%) |
| Sept 2018 | - | $14.21 M(-10.3%) |
| June 2018 | - | $15.84 M(-31.2%) |
| Mar 2018 | - | $23.02 M(-14.2%) |
| Dec 2017 | $26.82 M(+680.7%) | $26.82 M(+15.5%) |
| Sept 2017 | - | $23.21 M(-13.0%) |
| June 2017 | - | $26.69 M(-11.5%) |
| Mar 2017 | - | $30.14 M(+777.5%) |
| Dec 2016 | $3.44 M(+6.6%) | $3.44 M(-39.9%) |
| Sept 2016 | - | $5.71 M(+118.9%) |
| June 2016 | - | $2.61 M(-55.3%) |
| Mar 2016 | - | $5.83 M(+81.0%) |
| Dec 2015 | $3.22 M(-128.8%) | $3.22 M(-349.7%) |
| Sept 2015 | - | -$1.29 M(-83.1%) |
| June 2015 | - | -$7.63 M(-32.5%) |
| Mar 2015 | - | -$11.30 M(+1.0%) |
| Dec 2014 | -$11.19 M(-70.4%) | -$11.19 M(-73.6%) |
| Sept 2014 | - | -$42.38 M(+5.6%) |
| June 2014 | - | -$40.13 M(+3.7%) |
| Mar 2014 | - | -$38.69 M(+2.2%) |
| Dec 2013 | -$37.86 M(+10.7%) | -$37.86 M |
| Dec 2012 | -$34.20 M | - |
FAQ
- What is Soleno Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly shareholders equity year-on-year change?
What is Soleno Therapeutics annual stockholders equity?
The current annual shareholders equity of SLNO is $157.51 M
What is the all time high annual shareholders equity for Soleno Therapeutics?
Soleno Therapeutics all-time high annual stockholders equity is $157.51 M
What is Soleno Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of SLNO is $264.70 M
What is the all time high quarterly shareholders equity for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly stockholders equity is $280.76 M
What is Soleno Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, SLNO quarterly stockholders equity has changed by +$107.19 M (+68.06%)